Literature DB >> 9104923

Results of heart transplantation in patients with preexisting malignancies.

M M Koerner1, G Tenderich, K Minami, H Mannebach, H Koertke, E zu Knyphausen, A El-Banayosy, D Baller, K Kleesiek, U Gleichmann, H Meyer, R Koerfer.   

Abstract

Twenty patients with end-stage heart failure and preexisting malignancies underwent heart transplantation at a single center, with a neoplasm-free interval before the procedure of 0 to 240 months. Twelve patients were long-term survivors (2 to 72 months); there were 2 early and 6 late deaths, thus justifying heart transplantation in patients with preexisting malignancies in individual cases.

Entities:  

Mesh：

Year:  1997        PMID： 9104923     DOI： 10.1016/s0002-9149(97)00031-3

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  5 in total

1.  Long-term follow-up of hearttransplant recipients with pre-transplant malignancies.

Authors:  Samuel D Ladowski; Milinda Abel; Linda Beatty; Margaret Scatena; Joseph S Ladowski
Journal:  Tex Heart Inst J       Date:  2006

2.  Risk factors and outcomes for the development of malignancy in lung and heart-lung transplant recipients.

Authors:  Michael J Metcalfe; Demetrios J Kutsogiannis; Kathy Jackson; Antigone Oreopoulous; John Mullen; Denis Modry; Justin Weinkauf; Dale C Lien; Ken C Stewart
Journal:  Can Respir J       Date:  2010 Jan-Feb       Impact factor: 2.409

3.  Pre-transplant malignancy: an analysis of outcomes after thoracic organ transplantation.

Authors:  Claude A Beaty; Timothy J George; Arman Kilic; John V Conte; Ashish S Shah
Journal:  J Heart Lung Transplant       Date:  2012-12-21       Impact factor: 10.247

4.  Solid organ transplantation after treatment for childhood cancer: a retrospective cohort analysis from the Childhood Cancer Survivor Study.

Authors:  Andrew C Dietz; Kristy Seidel; Wendy M Leisenring; Daniel A Mulrooney; Jean M Tersak; Richard D Glick; Cathy A Burnweit; Daniel M Green; Lisa R Diller; Susan A Smith; Rebecca M Howell; Marilyn Stovall; Gregory T Armstrong; Kevin C Oeffinger; Leslie L Robison; Amanda M Termuhlen
Journal:  Lancet Oncol       Date:  2019-08-27       Impact factor: 41.316

Review 5.  Severe Cardiac Toxicity Induced by Cancer Therapies Requiring Intensive Care Unit Admission.

Authors:  Andrea Montisci; Vittorio Palmieri; Jennifer E Liu; Maria T Vietri; Silvia Cirri; Francesco Donatelli; Claudio Napoli
Journal:  Front Cardiovasc Med       Date:  2021-09-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.